IFRX: Renal focus and strong funding drive development of a best-in-class C5aR blocker for ANCA vasculitisQuartr·3 hours agoIFRX+1.44%
Cullinan Therapeutics: Zipalertinib + chemo cuts median PFS to 14.5 vs 8.5 months in REZILIENT3TradingView·6 hours agoCGEM+1.36%
HELP: Phase III data for a novel adjunctive MDD therapy expected in Q4, with NDA filing targeted for 2028Quartr·Sep 11 at 02:01 PM
CAMP: Phase I trial for SYNGAP1 to launch in Q4, leveraging global sites and robust preclinical dataQuartr·Sep 9 at 06:50 PM
Actuate reports preclinical synergy of elraglusib with RAS inhibitors in pancreatic cancer modelsPUBT·Sep 9 at 11:10 AMACTU-2.80%
BHG Group Issues Corrected Notice for 2026 Annual General MeetingTip Ranks·Mar 31 at 03:49 PMUHT+1.71%AFJKR0.00%
U.S. stock market update: AIMEI HEALTH down 11.31%, trading volume increased, market sentiment fluctuations attract attentionPrice Alert·Mar 16 at 07:46 PMAFJKR0.00%
Pre-market hot trades in US stocks: Nike pre-market down 9.64%; AIMEI HEALTH TECHNOLOGY CO LTD COM USD0.0001 (SUB/RIGHTS 17/11/2028) pre-market up 9.49%Price Alert·Dec 19, 2025 at 09:27 AMNKE+0.80%AFJKR0.00%
AIMEI HEALTH TECHNOLOGY CO LTD COM USD0.0001 (SUB/RIGHTS 17/11/2028) | 10-Q: FY2025 Q3 Revenue: USD 0Earnings Watch·Nov 18, 2025 at 09:09 PMAFJKR0.00%
U.S. stock market update: AIMEI HEALTH TECHNOLOGY CO LTD COM USD0.0001 (SUB/RIGHTS 17/11/2028) down 11.34%Price Alert·Oct 14, 2025 at 06:26 PMAFJKR0.00%
U.S. stock market update: AIMEI HEALTH TECHNOLOGY CO LTD COM USD0.0001 (SUB/RIGHTS 17/11/2028) up 22.37%Price Alert·Oct 1, 2025 at 04:16 PMAFJKR0.00%
U.S. stock market update: AIMEI HEALTH TECHNOLOGY CO LTD COM USD0.0001 (SUB/RIGHTS 17/11/2028) up 19.57%Price Alert·Sep 17, 2025 at 07:11 PMAFJKR0.00%
AIMEI HEALTH TECHNOLOGY CO LTD COM USD0.0001 (SUB/RIGHTS 17/11/2028) | 10-Q: FY2025 Q2 EPS: USD 0.09Earnings Watch·Aug 13, 2025 at 08:09 PMAFJKR0.00%
AIMEI HEALTH TECHNOLOGY CO LTD COM USD0.0001 (SUB/RIGHTS 17/11/2028) | 10-Q: FY2025 Q1 EPS: USD 0.03Earnings Watch·May 14, 2025 at 08:47 PMAFJKR0.00%
